In order to assess whether tumoral C5a has potential significance in predicting clinical outcome of ccRCC patients, Kaplan-Meier analyses were applied to compare OS and DFS in different C5a leveled patients. This evidence concerns the gene C5 and nonpapillary renal cell carcinoma.